Head office: +98 21 8854 0521 Saturday to Wednesday, 8:00–17:00 info@meshcutpharmed.com Contact usPartnership
Meshkat Pharmed DistributionMeshkat Pharmed DistributionNationwide distribution of medicines and health products
News & articles

Meshkat Pharmed newsand health articles

The latest company news, events in the pharmaceutical distribution industry and educational articles

NewsNovember 16, 2026

Lili product introduction session held

An introduction and unveiling session for the Lili platform was held with the Holding’s owner, the CEO and managers of the Meshkat group. During the session, Eng. Abiri explained the…

Read more
NewsNovember 15, 2026

Product introduction session held at Meshkat Pharmed Distribution

A session introducing Vartagen 15% topical ointment was held at Meshkat Pharmed Distribution with representatives of Nahal Darou Hafez Salamat and colleagues from the commercial and sales…

Read more
ArticleNovember 11, 2026

UK regulator bans stem-cell treatment ads as “misleading”

The UK advertising watchdog has banned ads from four companies promoting stem-cell treatment for autism in children, ruling them misleading.

Read more
ArticleNovember 11, 2026

Is heart damage from anabolic steroids reversible?

According to a longitudinal study with 6 to 8 years of follow-up, long-term use of anabolic-androgenic steroids (AAS) in male strength athletes is associated with persistent cardiac…

Read more
ArticleNovember 3, 2026

Fibroid drug relugolix may act as a contraceptive

According to research presented at the American Society for Reproductive Medicine (ASRM) 2026 meeting, relugolix (Orgovyx) — used in combination with estradiol and norethindrone acetate to…

Read more
ArticleNovember 1, 2026

Naronapride eases gastroparesis symptoms in phase 2 trial

In a phase 2b trial, naronapride — an investigational dual-action prokinetic given at 20 or 40 mg three times daily for 12 weeks — led to significantly greater improvement in core symptoms…

Read more
NewsOctober 27, 2026

Brainstorming session of the commercial & sales division with the CEO and owner of Meshkat Pharmed Distribution

A brainstorming session of the commercial and sales division of Meshkat Pharmed Distribution was held with the company’s CEO and owner.

Read more
NewsOctober 24, 2026

Featured news: Meshkat Pharmaceutical and Medical Holding invests in technologies to extend human lifespan

Mohsen Mazaheri, owner of the Meshkat Pharmaceutical and Medical Holding, has announced the group’s strategic plan to invest in biotechnology, modern medicine and research related to…

Read more
ArticleOctober 21, 2026

Edible batteries could power medical devices inside the body

A battery made from an edible material similar to “rice paper” could power ingestible electronic medical devices. Once safely digested in the gastrointestinal tract, its broken-down…

Read more
ArticleOctober 20, 2026

Navepegritide: first approval

Navepegritide is a C-type natriuretic peptide (CNP) prodrug developed by Ascendis Pharma for the treatment of achondroplasia and under investigation for hypochondroplasia. Given once…

Read more
ArticleOctober 18, 2026

Genetic and environmental risk factors for asthma

Asthma is a common chronic airway disease affecting approximately 260 million people of all ages worldwide and causing substantial morbidity, mortality and economic burden. Asthma is…

Read more
ArticleOctober 14, 2026

Supplements and wellness products during cancer care

Many people with cancer consider supplements or wellness products during treatment. Some hope to improve energy, support the immune system, reduce treatment side effects or feel more in…

Read more
ArticleOctober 13, 2026

First combination of acetaminophen and naproxen sodium approved

The US Food and Drug Administration (FDA) has approved the first combination tablet of acetaminophen with naproxen sodium, a nonsteroidal anti-inflammatory drug (NSAID).

Read more
NewsOctober 12, 2026

Dr. Nowruzi, distinguished professor at Tehran University of Medical Sciences, appointed Chair of the Meshkat Holding’s Supreme Council for Scientific Policy

Dr. Mehdi Nowruzi, professor of molecular genetics at Tehran University of Medical Sciences, has been appointed Chair of the Meshkat Holding’s Supreme Council for Scientific Policy.

Read more
ArticleOctober 10, 2026

From sleep to vaccination: what really helps your immune system?

When it comes to preventing disease, the phrase “boosting the immune system” is almost everywhere — from ads for supplements and herbal teas to advice on social media. But can a single pill…

Read more
ArticleOctober 7, 2026

What is pneumonic plague? Symptoms, transmission, treatment and the case in Russia

Pneumonic plague is one of the most severe forms of plague, caused by the bacterium Yersinia pestis. Contrary to some content circulating online, plague is neither a new disease nor a viral…

Read more
ArticleSeptember 19, 2026

The role of reputable sports and nutritional supplements in improving public health

With rising public awareness of healthy lifestyles and exercise, demand for sports supplements (such as whey protein and amino acids) and nutritional supplements has increased sharply.…

Read more
NewsSeptember 19, 2026

The importance of the cold chain in pharmaceutical distribution: our commitment to GSP and GDP

Preserving the quality and efficacy of medicines from the moment they leave the factory until they reach the pharmacy is one of the biggest challenges in the distribution industry.…

Read more
NewsSeptember 19, 2026

Expanding our last-mile distribution network: Meshkat Pharmed serves more than 10,000 healthcare centers

Since its founding in 2017 (1396 in the Iranian calendar), Meshkat Pharmed Distribution has always emphasized sustainable development and fair access to health products. We are proud to…

Read more